Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium
- PMID: 17163238
- DOI: 10.2165/00044011-200626020-00003
Healthcare use, social burden and costs of children with and without ADHD in Flanders, Belgium
Abstract
Background: The purpose of this study was to provide quantitative information on the economic, social and emotional burden borne by families of children with attention-deficit hyperactivity disorder (ADHD) and on the public healthcare costs of a child with ADHD in Flanders, Belgium, and to compare costs of ADHD children with those of siblings without the disorder.
Methods: A pilot-tested questionnaire was sent to all members of the Flemish ADHD society in February 2003. Parents were asked to record utilisation of healthcare, social care and other non-medical resources for their ADHD child and his/her sibling. In addition, data were collected on ADHD severity (IOWA-Conners Rating Scale) and on the sociodemographic and economic characteristics of the parents. Parents' out-of-pocket and public annual costs were calculated using tariffs. These costs were corrected for several confounding variables using general linear model (GLM) estimates.
Results: ADHD affects school results and parents' productivity and places a psychological and emotional burden on the family. Childhood ADHD also results in a significantly higher use of healthcare: ADHD children have a significantly higher probability of visiting a general practitioner (60.3% vs 37.4%) and a specialist (50.9% vs 12.9%); they also visit the emergency department significantly more often (26% vs 12.1%), and they are hospitalised significantly more often (14% vs 8.4%). Consequently, Flemish children with ADHD incur significantly higher medical costs than their siblings without the disorder. Even after correction for several covariates, these cost differences are still striking. In fact, compared with their sibling, the annual cost for an ADHD child is more than six times higher for the parent (Euro 588.3 vs Euro 91.5), and public costs are twice as high (Euro 779 vs Euro 371.3) [year of costing 2002].
Conclusions: Childhood ADHD results in significantly higher use of healthcare and adversely affects academic achievements and parents' productivity.
Similar articles
-
Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD).Eur Child Adolesc Psychiatry. 2007 Aug;16(5):316-26. doi: 10.1007/s00787-007-0603-6. Epub 2007 May 4. Eur Child Adolesc Psychiatry. 2007. PMID: 17483870
-
The economic burden of adult attention deficit hyperactivity disorder: A sibling comparison cost analysis.Eur Psychiatry. 2019 Sep;61:41-48. doi: 10.1016/j.eurpsy.2019.06.011. Epub 2019 Jul 6. Eur Psychiatry. 2019. PMID: 31288209
-
Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: a descriptive analysis.BMC Psychiatry. 2018 Feb 8;18(1):40. doi: 10.1186/s12888-017-1581-y. BMC Psychiatry. 2018. PMID: 29422022 Free PMC article.
-
Economic implications of attention-deficit hyperactivity disorder for healthcare systems.Pharmacoeconomics. 2003;21(17):1239-62. doi: 10.2165/00019053-200321170-00002. Pharmacoeconomics. 2003. PMID: 14986737 Review.
-
Economic impact of childhood and adult attention-deficit/hyperactivity disorder in the United States.J Am Acad Child Adolesc Psychiatry. 2012 Oct;51(10):990-1002.e2. doi: 10.1016/j.jaac.2012.07.008. Epub 2012 Sep 5. J Am Acad Child Adolesc Psychiatry. 2012. PMID: 23021476 Review.
Cited by
-
Association between societal costs and treatment response in children and adolescents with ADHD and their parents. A cross-sectional study in the Netherlands.Springerplus. 2015 May 15;4:224. doi: 10.1186/s40064-015-0978-7. eCollection 2015. Springerplus. 2015. PMID: 26155437 Free PMC article.
-
Females with ADHD: An expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit/ hyperactivity disorder in girls and women.BMC Psychiatry. 2020 Aug 12;20(1):404. doi: 10.1186/s12888-020-02707-9. BMC Psychiatry. 2020. PMID: 32787804 Free PMC article.
-
Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?Pharmacoeconomics. 2015 May;33(5):489-509. doi: 10.1007/s40273-015-0259-x. Pharmacoeconomics. 2015. PMID: 25715975 Free PMC article.
-
A systematic review of global publication trends regarding long-term outcomes of ADHD.Front Psychiatry. 2012 Jan 18;2:84. doi: 10.3389/fpsyt.2011.00084. eCollection 2011. Front Psychiatry. 2012. PMID: 22279437 Free PMC article.
-
Societal costs and quality of life of children suffering from attention deficient hyperactivity disorder (ADHD).Eur Child Adolesc Psychiatry. 2007 Aug;16(5):316-26. doi: 10.1007/s00787-007-0603-6. Epub 2007 May 4. Eur Child Adolesc Psychiatry. 2007. PMID: 17483870
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical